19-17762832-T-C
Position:
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM2PP3_Strong
The NM_015122.3(FCHO1):c.98T>C(p.Leu33Pro) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: not found (cov: 31)
Consequence
FCHO1
NM_015122.3 missense
NM_015122.3 missense
Scores
13
4
2
Clinical Significance
Conservation
PhyloP100: 7.25
Genes affected
FCHO1 (HGNC:29002): (FCH and mu domain containing endocytic adaptor 1) Enables AP-2 adaptor complex binding activity. Involved in clathrin coat assembly and clathrin-dependent endocytosis. Located in cytosol; nucleoplasm; and plasma membrane. Is active in clathrin-coated pit. Implicated in primary immunodeficiency disease. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.979
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FCHO1 | NM_015122.3 | c.98T>C | p.Leu33Pro | missense_variant | 5/29 | ENST00000596536.6 | NP_055937.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FCHO1 | ENST00000596536.6 | c.98T>C | p.Leu33Pro | missense_variant | 5/29 | 5 | NM_015122.3 | ENSP00000470731.1 | ||
FCHO1 | ENST00000699212.1 | c.98T>C | p.Leu33Pro | missense_variant | 5/30 | ENSP00000514208.1 | ||||
FCHO1 | ENST00000594202.6 | c.98T>C | p.Leu33Pro | missense_variant | 5/29 | 5 | ENSP00000473001.1 | |||
FCHO1 | ENST00000596309.6 | c.98T>C | p.Leu33Pro | missense_variant | 5/29 | 4 | ENSP00000470511.2 | |||
FCHO1 | ENST00000596951.6 | c.98T>C | p.Leu33Pro | missense_variant | 5/29 | 5 | ENSP00000472417.1 | |||
FCHO1 | ENST00000600209.6 | c.98T>C | p.Leu33Pro | missense_variant | 5/29 | 5 | ENSP00000469075.2 | |||
FCHO1 | ENST00000600676.5 | c.98T>C | p.Leu33Pro | missense_variant | 4/28 | 2 | ENSP00000470493.1 | |||
FCHO1 | ENST00000699176.1 | c.98T>C | p.Leu33Pro | missense_variant | 5/29 | ENSP00000514179.1 | ||||
FCHO1 | ENST00000699177.1 | c.98T>C | p.Leu33Pro | missense_variant | 5/29 | ENSP00000514180.1 | ||||
FCHO1 | ENST00000699207.1 | c.98T>C | p.Leu33Pro | missense_variant | 5/29 | ENSP00000514204.1 | ||||
FCHO1 | ENST00000699209.1 | c.98T>C | p.Leu33Pro | missense_variant | 5/29 | ENSP00000514206.1 | ||||
FCHO1 | ENST00000699215.1 | c.98T>C | p.Leu33Pro | missense_variant | 4/28 | ENSP00000514211.1 | ||||
FCHO1 | ENST00000699202.1 | c.98T>C | p.Leu33Pro | missense_variant | 5/29 | ENSP00000514200.1 | ||||
FCHO1 | ENST00000699214.1 | c.98T>C | p.Leu33Pro | missense_variant | 4/28 | ENSP00000514210.1 | ||||
FCHO1 | ENST00000699208.1 | c.98T>C | p.Leu33Pro | missense_variant | 5/28 | ENSP00000514205.1 | ||||
FCHO1 | ENST00000699198.1 | c.98T>C | p.Leu33Pro | missense_variant | 5/29 | ENSP00000514196.1 | ||||
FCHO1 | ENST00000699199.1 | c.98T>C | p.Leu33Pro | missense_variant | 4/28 | ENSP00000514197.1 | ||||
FCHO1 | ENST00000699213.1 | c.98T>C | p.Leu33Pro | missense_variant | 4/28 | ENSP00000514209.1 | ||||
FCHO1 | ENST00000699197.1 | c.98T>C | p.Leu33Pro | missense_variant | 5/28 | ENSP00000514195.1 | ||||
FCHO1 | ENST00000699200.1 | c.98T>C | p.Leu33Pro | missense_variant | 5/28 | ENSP00000514198.1 | ||||
FCHO1 | ENST00000699196.1 | c.98T>C | p.Leu33Pro | missense_variant | 5/27 | ENSP00000514194.1 | ||||
FCHO1 | ENST00000699203 | c.-53T>C | 5_prime_UTR_variant | 3/22 | ENSP00000514201.1 | |||||
FCHO1 | ENST00000699201.1 | n.98T>C | non_coding_transcript_exon_variant | 5/28 | ENSP00000514199.1 | |||||
FCHO1 | ENST00000699205.1 | n.98T>C | non_coding_transcript_exon_variant | 5/27 | ENSP00000514202.1 | |||||
FCHO1 | ENST00000699206.1 | n.98T>C | non_coding_transcript_exon_variant | 5/29 | ENSP00000514203.1 | |||||
FCHO1 | ENST00000699210.1 | n.98T>C | non_coding_transcript_exon_variant | 5/28 | ENSP00000514207.1 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD3 genomes
Cov.:
31
GnomAD4 exome Cov.: 30
GnomAD4 exome
Cov.:
30
GnomAD4 genome Cov.: 31
GnomAD4 genome
Cov.:
31
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 05, 2022 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. ClinVar contains an entry for this variant (Variation ID: 1393176). This variant has not been reported in the literature in individuals affected with FCHO1-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces leucine, which is neutral and non-polar, with proline, which is neutral and non-polar, at codon 33 of the FCHO1 protein (p.Leu33Pro). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Pathogenic
DEOGEN2
Benign
T;T;T;T;T;.;T;T;T;T;.;.;.;T;T;.;T;T;.
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D;.;D;D;D;D;.;D;D;D;D;D;D;D;D;.;D;D
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D
MetaSVM
Uncertain
T
MutationAssessor
Pathogenic
.;M;M;.;.;.;.;M;.;.;.;.;.;.;.;.;M;.;.
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
.;D;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.
REVEL
Pathogenic
Sift
Pathogenic
.;D;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.
Sift4G
Pathogenic
D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D
Polyphen
1.0
.;D;D;.;.;.;.;D;.;.;.;.;.;.;.;.;D;.;.
Vest4
MutPred
Gain of disorder (P = 0.0081);Gain of disorder (P = 0.0081);Gain of disorder (P = 0.0081);Gain of disorder (P = 0.0081);Gain of disorder (P = 0.0081);Gain of disorder (P = 0.0081);Gain of disorder (P = 0.0081);Gain of disorder (P = 0.0081);Gain of disorder (P = 0.0081);Gain of disorder (P = 0.0081);Gain of disorder (P = 0.0081);Gain of disorder (P = 0.0081);Gain of disorder (P = 0.0081);Gain of disorder (P = 0.0081);Gain of disorder (P = 0.0081);Gain of disorder (P = 0.0081);Gain of disorder (P = 0.0081);Gain of disorder (P = 0.0081);.;
MVP
MPC
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.